Chordoma (poorly differentiated or de-differentiated)
Showing 1 - 25 of 6,119
Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
- (no location specified)
Oct 25, 2023
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of
Completed
- Gallbladder Cancer
- laparoscopic whole-layer cholecystectomy
-
Ōita, Oita, Japanoita Red Cross hospital
Sep 24, 2022
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)
Active, not recruiting
- Neuroendocrine Carcinoma
-
Aix-en-Provence, France
- +6 more
Mar 9, 2022
Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Oviedo, Asturias, Spain
- +9 more
Dec 14, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T
Recruiting
- Anaplastic Thyroid Cancer
- Relapsed/Refractory Poorly Differentiated Thyroid Cancer
- AIC100 CAR T Cells
-
New York, New YorkWeill Cornell Medical College
Feb 14, 2022
Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)
Active, not recruiting
- Differentiated Thyroid Cancer (DTC)
- Poorly Differentiated Thyroid Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)
Recruiting
- Neuroendocrine Tumours (NET)
- Neuroendocrine Carcinomas (NEC)
-
Santiago De Compostela, Galicia, Spain
- +4 more
Aug 1, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)
Not yet recruiting
- GEP-NET
- nanoliposomal irinotecan plus carboplatin
-
Kaohsiung, Taiwan
- +5 more
May 17, 2022
Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8
Suspended
- Metastatic Thyroid Gland Carcinoma
- +2 more
- Lenvatinib
- +2 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Low Risk Differentiated Thyroid Cancer Trial in Villejuif (rhTSH stimulation, I131, Follow up)
Active, not recruiting
- Low Risk Differentiated Thyroid Cancer
- rhTSH stimulation
- +2 more
-
Villejuif, Val De Marne, FranceInstitut Gustave Roussy
Dec 7, 2021
Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)
Recruiting
- Neuroendocrine Carcinoma
- FOLFOXIRI Protocol
- Cisplatin injection
-
Caen, France
- +5 more
Apr 13, 2021
Thyroid Cancer Metastatic Trial in France (Lenvatinib + Denosumab)
Recruiting
- Thyroid Cancer Metastatic
- Lenvatinib + Denosumab
-
Angers, France
- +13 more
Mar 14, 2022
Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,
Completed
- Well-differentiated Non-functional NET of Thoracic Origin
- +3 more
-
Duarte, California
- +34 more
Mar 16, 2021
Thyroid Cancer Trial in Villejuif (total thyroidectomy with bilateral prophylactic central compartment (level VI) neck
Recruiting
- Thyroid Cancer
- total thyroidectomy with bilateral prophylactic central compartment (level VI) neck dissection
- total thyroidectomy alone without neck dissection
-
Villejuif, Val De Marne, FranceGustave Roussy
Dec 20, 2021
Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)
Recruiting
- Neuroendocrine Carcinomas
-
Amiens, France
- +26 more
Jan 26, 2022
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )
Recruiting
- Differentiated Thyroid Cancer
- Dabrafenib
- +3 more
-
Caba, Buenos Aires, Argentina
- +41 more
Nov 25, 2022
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +16 more
- Elimusertib
- +2 more
-
Phoenix, Arizona
- +10 more
Mar 25, 2022
Vulvar Intraepithelial Neoplasia, Vulvar High Grade Squamous Intraepithelial Lesion, Differentiated Vulvar Intraepithelial
Recruiting
- Vulvar Intraepithelial Neoplasia
- +2 more
- Metvixia Topical Cream
-
Vandœuvre-lès-Nancy, FranceInstitut de Cancerologie de Lorraine
Dec 3, 2021